anti-IL-12p40/IL-23p40 human monoclonal antibodies (Theraclone Sciences)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-IL-12p40/IL-23p40 human monoclonal antibodies (Theraclone Sciences)
Drug Alias Nameanti-IL-12p40/IL-23p40 human mAbs (Theraclone Sciences)anti-Interleukin-12p40/Interleukin-23p40 human monoclonal antibodies (Theraclone Sciences)anti-IL-12/23 p40 human monoclonal antibodies (Theraclone Sciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-23 inhibitorsInterleukin-12 receptor inhibitors
TargetsInterleukin-23Interleukin-12 receptor
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheraclone Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheraclone Sciences Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A